ID UBA1_RAT Reviewed; 1058 AA. AC Q5U300; DT 03-MAR-2009, integrated into UniProtKB/Swiss-Prot. DT 07-DEC-2004, sequence version 1. DT 27-MAR-2024, entry version 148. DE RecName: Full=Ubiquitin-like modifier-activating enzyme 1 {ECO:0000250|UniProtKB:Q02053}; DE EC=6.2.1.45 {ECO:0000250|UniProtKB:P22314}; DE AltName: Full=Ubiquitin-activating enzyme E1 {ECO:0000250|UniProtKB:Q02053}; GN Name=Uba1 {ECO:0000312|EMBL:AAH85791.1, ECO:0000312|RGD:1359327}; GN Synonyms=Ube1 {ECO:0000250|UniProtKB:Q02053}; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] {ECO:0000305, ECO:0000312|EMBL:EDL97701.1} RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [2] {ECO:0000312|EMBL:AAH85791.1} RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Brown Norway {ECO:0000269|PubMed:15489334}; RC TISSUE=Kidney {ECO:0000312|EMBL:AAH85791.1}; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] {ECO:0000305, ECO:0000312|EMBL:EDL97701.1} RP IDENTIFICATION BY MASS SPECTROMETRY. RA Maurya D.K., Bhargava P.; RL Submitted (JAN-2009) to UniProtKB. RN [4] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-835, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22673903; DOI=10.1038/ncomms1871; RA Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C., RA Olsen J.V.; RT "Quantitative maps of protein phosphorylation sites across 14 different rat RT organs and tissues."; RL Nat. Commun. 3:876-876(2012). CC -!- FUNCTION: Catalyzes the first step in ubiquitin conjugation to mark CC cellular proteins for degradation through the ubiquitin-proteasome CC system. Activates ubiquitin by first adenylating its C-terminal glycine CC residue with ATP, and thereafter linking this residue to the side chain CC of a cysteine residue in E1, yielding a ubiquitin-E1 thioester and free CC AMP. Essential for the formation of radiation-induced foci, timely DNA CC repair and for response to replication stress. Promotes the recruitment CC of TP53BP1 and BRCA1 at DNA damage sites. CC {ECO:0000250|UniProtKB:P22314}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + ubiquitin + [E1 ubiquitin-activating enzyme]-L-cysteine CC = AMP + diphosphate + S-ubiquitinyl-[E1 ubiquitin-activating enzyme]- CC L-cysteine.; EC=6.2.1.45; Evidence={ECO:0000250|UniProtKB:P22314}; CC -!- PATHWAY: Protein modification; protein ubiquitination. CC {ECO:0000250|UniProtKB:P22314}. CC -!- SUBUNIT: Monomer. Interacts with GAN (via BTB domain) (By similarity). CC {ECO:0000250|UniProtKB:Q02053}. CC -!- INTERACTION: CC Q5U300; Q9H2C0: GAN; Xeno; NbExp=2; IntAct=EBI-40204881, EBI-764342; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P22314}. CC Mitochondrion {ECO:0000250|UniProtKB:P22314}. Nucleus CC {ECO:0000250|UniProtKB:P22314}. CC -!- PTM: ISGylated. {ECO:0000250|UniProtKB:P22314}. CC -!- MISCELLANEOUS: There are two active sites within the E1 molecule, CC allowing it to accommodate two ubiquitin moieties at a time, with a new CC ubiquitin forming an adenylate intermediate as the previous one is CC transferred to the thiol site. {ECO:0000250|UniProtKB:P22515}. CC -!- SIMILARITY: Belongs to the ubiquitin-activating E1 family. CC {ECO:0000255}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CH474009; EDL97701.1; -; Genomic_DNA. DR EMBL; CH474009; EDL97702.1; -; Genomic_DNA. DR EMBL; BC085791; AAH85791.1; -; mRNA. DR RefSeq; NP_001014102.1; NM_001014080.1. DR RefSeq; XP_006256674.1; XM_006256612.3. DR RefSeq; XP_006256675.2; XM_006256613.3. DR AlphaFoldDB; Q5U300; -. DR BMRB; Q5U300; -. DR SMR; Q5U300; -. DR BioGRID; 260716; 4. DR IntAct; Q5U300; 1. DR STRING; 10116.ENSRNOP00000033950; -. DR GlyGen; Q5U300; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q5U300; -. DR PhosphoSitePlus; Q5U300; -. DR SwissPalm; Q5U300; -. DR jPOST; Q5U300; -. DR PaxDb; 10116-ENSRNOP00000033950; -. DR Ensembl; ENSRNOT00055028048; ENSRNOP00055022563; ENSRNOG00055016495. DR Ensembl; ENSRNOT00060037267; ENSRNOP00060030747; ENSRNOG00060021167. DR Ensembl; ENSRNOT00065034509; ENSRNOP00065027656; ENSRNOG00065020374. DR GeneID; 314432; -. DR KEGG; rno:314432; -. DR UCSC; RGD:1359327; rat. DR AGR; RGD:1359327; -. DR CTD; 7317; -. DR RGD; 1359327; Uba1. DR VEuPathDB; HostDB:ENSRNOG00000019164; -. DR eggNOG; KOG2012; Eukaryota. DR HOGENOM; CLU_002556_0_0_1; -. DR InParanoid; Q5U300; -. DR OrthoDB; 20494at2759; -. DR PhylomeDB; Q5U300; -. DR TreeFam; TF300586; -. DR Reactome; R-RNO-8866652; Synthesis of active ubiquitin: roles of E1 and E2 enzymes. DR Reactome; R-RNO-983168; Antigen processing: Ubiquitination & Proteasome degradation. DR UniPathway; UPA00143; -. DR PRO; PR:Q5U300; -. DR Proteomes; UP000002494; Chromosome X. DR Proteomes; UP000234681; Chromosome x. DR Bgee; ENSRNOG00000019164; Expressed in spleen and 19 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0000792; C:heterochromatin; ISO:RGD. DR GO; GO:0005739; C:mitochondrion; ISS:UniProtKB. DR GO; GO:0005634; C:nucleus; ISS:UniProtKB. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0004839; F:ubiquitin activating enzyme activity; ISO:RGD. DR GO; GO:0006974; P:DNA damage response; ISO:RGD. DR GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central. DR GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central. DR CDD; cd01491; Ube1_repeat1; 1. DR CDD; cd01490; Ube1_repeat2; 1. DR Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1. DR Gene3D; 2.40.30.180; Ubiquitin-activating enzyme E1, FCCH domain; 1. DR Gene3D; 3.50.50.80; Ubiquitin-activating enzyme E1, inactive adenylation domain, subdomain 1; 1. DR Gene3D; 3.40.50.12550; Ubiquitin-activating enzyme E1, inactive adenylation domain, subdomain 2; 1. DR Gene3D; 1.10.10.2660; Ubiquitin-activating enzyme E1, SCCH domain; 1. DR Gene3D; 3.10.290.60; Ubiquitin-activating enzyme E1, UFD domain; 1. DR InterPro; IPR032420; E1_4HB. DR InterPro; IPR032418; E1_FCCH. DR InterPro; IPR042302; E1_FCCH_sf. DR InterPro; IPR045886; ThiF/MoeB/HesA. DR InterPro; IPR000594; ThiF_NAD_FAD-bd. DR InterPro; IPR018965; Ub-activating_enz_E1_C. DR InterPro; IPR042449; Ub-E1_IAD_1. DR InterPro; IPR038252; UBA_E1_C_sf. DR InterPro; IPR019572; UBA_E1_SCCH. DR InterPro; IPR042063; Ubi_acti_E1_SCCH. DR InterPro; IPR035985; Ubiquitin-activating_enz. DR InterPro; IPR018075; UBQ-activ_enz_E1. DR InterPro; IPR018074; UBQ-activ_enz_E1_CS. DR InterPro; IPR033127; UBQ-activ_enz_E1_Cys_AS. DR InterPro; IPR000011; UBQ/SUMO-activ_enz_E1-like. DR NCBIfam; TIGR01408; Ube1; 1. DR PANTHER; PTHR10953; UBIQUITIN-ACTIVATING ENZYME E1; 1. DR PANTHER; PTHR10953:SF155; UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 1; 1. DR Pfam; PF16191; E1_4HB; 1. DR Pfam; PF16190; E1_FCCH; 1. DR Pfam; PF09358; E1_UFD; 1. DR Pfam; PF00899; ThiF; 2. DR Pfam; PF10585; UBA_E1_SCCH; 1. DR PRINTS; PR01849; UBIQUITINACT. DR SMART; SM00985; UBA_e1_C; 1. DR SUPFAM; SSF69572; Activating enzymes of the ubiquitin-like proteins; 2. DR PROSITE; PS00536; UBIQUITIN_ACTIVAT_1; 1. DR PROSITE; PS00865; UBIQUITIN_ACTIVAT_2; 1. DR Genevisible; Q5U300; RN. PE 1: Evidence at protein level; KW Acetylation; ATP-binding; Cytoplasm; Ligase; Mitochondrion; KW Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat; KW Ubl conjugation; Ubl conjugation pathway. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:P22314" FT CHAIN 2..1058 FT /note="Ubiquitin-like modifier-activating enzyme 1" FT /id="PRO_0000365096" FT REPEAT 63..199 FT /note="1-1" FT /evidence="ECO:0000255" FT REPEAT 459..611 FT /note="1-2" FT /evidence="ECO:0000255" FT REGION 1..46 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 63..611 FT /note="2 approximate repeats" FT /evidence="ECO:0000255" FT COMPBIAS 18..42 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 632 FT /note="Glycyl thioester intermediate" FT /evidence="ECO:0000250|UniProtKB:Q02053, FT ECO:0000255|PROSITE-ProRule:PRU10132" FT BINDING 478 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22515" FT BINDING 504 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22515" FT BINDING 515 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22515" FT BINDING 528 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22515" FT BINDING 576..577 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22515" FT MOD_RES 2 FT /note="N-acetylserine" FT /evidence="ECO:0000250|UniProtKB:P22314" FT MOD_RES 4 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P22314" FT MOD_RES 13 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P22314" FT MOD_RES 21 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q02053" FT MOD_RES 24 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q02053" FT MOD_RES 46 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:22673903" FT MOD_RES 55 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q02053" FT MOD_RES 528 FT /note="N6-succinyllysine" FT /evidence="ECO:0000250|UniProtKB:Q02053" FT MOD_RES 671 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P22314" FT MOD_RES 800 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P22314" FT MOD_RES 810 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P22314" FT MOD_RES 816 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q02053" FT MOD_RES 820 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P22314" FT MOD_RES 835 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:22673903" FT MOD_RES 980 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P22314" SQ SEQUENCE 1058 AA; 117788 MW; FAC21190A3014F79 CRC64; MSSSPLSKKR RVSGPDPKPG SNCSSAQSVL SEVSSVPTNG MAKNGSEADI DESLYSRQLY VLGHEAMKML QTSSVLVSGL RGLGVEIAKN IILGGVKAVT LHDQGTTQWA DLSSQFYLRE EDIGKNRAEV SQPRLAELNS YVPVTAYTGP LVEDFLSGFQ VVVLTNSPLE EQLRVGEFCH SRGIKLVVAD TRGLFGQLFC DFGEEMVLTD SNGEQPLSAM VSMVTKDNPG VVTCLDEARH GFETGDFVSF SEVQGMVQLN GCQPIEIKVL GPYTFSICDT SNFSDYIRGG IVSQVKVPKK ISFKSLPASL AEPDFVMTDF AKYSRPAQLH IGFQALHQFC AQHNRPPRPR NEEDATELVT LAQAVNARSP PAVQQDNVDE DLIRKLAYVA AGDLAPINAF IGGLAAQEVM KACSGKFMPI MQWLYFDALE CLPEDKEALT EDKCLPRQNR YDGQVAVFGS DLQEKLGKQK YFLVGAGAIG CELLKNFAMI GLGCGEGGEV VVTDMDTIEK SNLNRQFLFR PWDVTKLKSD TAAAAVRQMN PYIQVTSHQN RVGPDTERIY DDDFFQNLDG VANALDNVDA RMYMDRRCVY YRKPLLESGT LGTKGNVQVV IPFLTESYSS SQDPPEKSIP ICTLKNFPNA IEHTLQWARD EFEGLFKQPA ENVNQYLTDS KFVERTLRLA GTQPLEVLEA VQRSLVLQRP QTWGDCVTWA CHHWHTQYCN NIRQLLHNFP PDQLTSSGAP FWSGPKRCPH PLTFDVNNTL HLDYVMAAAN LFAQTYGLTG SQDRAAVASL LQSVQVPEFT PKSGVKIHVS DQELQSANAS VDDSRLEELK ATLPSPDKLP GFKMYPIDFE KDDDSNFHMD FIVAASNLRA ENYDISPADR HKSKLIAGKI IPAIATTTAA VVGLVCLELY KVVQGHQQLD SYKNGFLNLA LPFFGFSEPL AAPRHQYYNQ EWTLWDRFEV QGLQPNGEEM TLKQFLDYFK TEHKLEITML SQGVSMLYSF FMPAAKLKER LDQPMTEIVS RVSKRKLGRH VRALVLELCC NDESGEDVEV PYVRYTIR //